An official website of the United States government
Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study
Trial Status: active
This study evaluates the effect of bladder cancer treatment on quality of life.
Inclusion Criteria
* > or = 18 years of age;
* Have pathologically confirmed, clinically localized, bladder cancer
* Be willing to complete a survey in English before starting definitive treatment (surgery or radiation);
* Able to give consent.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT06350734.
I. To compare general and disease-specific quality of life outcomes at 6, 12, 24, and 36 months after treatment for localized bladder cancer using the PROMIS-29 and the Bladder Cancer Index (BCI) respectively.
II. To identify patient level characteristics that may influence quality of life outcomes after treatment for localized bladder cancer.
OUTLINE: This is an observational study.
Patients complete surveys and also have their medical records reviewed on study.
